NYSE:USPH - U.S. Physical Therapy Stock Price, Forecast & News

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have decreased by 36.0% and is now trading at $59.63. View which stocks have been mosted impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for U.S. Physical Therapy.

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for U.S. Physical Therapy.

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings data on Thursday, February, 27th. The company reported $0.64 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.68 by $0.04. The company earned $122.11 million during the quarter, compared to analysts' expectations of $121.45 million. U.S. Physical Therapy had a net margin of 6.63% and a return on equity of 15.75%. U.S. Physical Therapy's revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the business earned $0.71 EPS. View U.S. Physical Therapy's earnings history.

U.S. Physical Therapy declared a quarterly dividend on Friday, February 28th. Stockholders of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 2.15%. The ex-dividend date is Thursday, March 12th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.30. View U.S. Physical Therapy's dividend history.

U.S. Physical Therapy updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 27th. The company provided earnings per share (EPS) guidance of 2.98-3.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.15.

3 brokerages have issued twelve-month price objectives for U.S. Physical Therapy's stock. Their forecasts range from $80.00 to $120.00. On average, they anticipate U.S. Physical Therapy's share price to reach $100.00 in the next twelve months. This suggests a possible upside of 67.7% from the stock's current price. View analysts' price targets for U.S. Physical Therapy.

Media stories about USPH stock have been trending very negative on Friday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. U.S. Physical Therapy earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutU.S. Physical Therapy.

U.S. Physical Therapy saw a drop in short interest in February. As of February 28th, there was short interest totaling 961,000 shares, a drop of 9.3% from the February 13th total of 1,060,000 shares. Based on an average daily trading volume, of 88,500 shares, the short-interest ratio is presently 10.9 days. Currently, 7.7% of the shares of the company are short sold. View U.S. Physical Therapy's Current Options Chain.

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Universal Health Services (UHS), The Ensign Group (ENSG), Select Medical (SEM), Acadia Healthcare (ACHC), Tenet Healthcare (THC), National HealthCare (NHC), Brookdale Senior Living (BKD), Hanger (HNGR), Community Health Systems (CYH), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), AbbVie (ABBV), IBM (IBM), Marathon Petroleum (MPC), AT&T (T), Gilead Sciences (GILD), Starbucks (SBUX), Allergan (AGN), Enbridge (ENB) and Ford Motor (F).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of USPH stock can currently be purchased for approximately $59.63.

U.S. Physical Therapy has a market capitalization of $761.77 million and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe. View additional information about U.S. Physical Therapy.

The official website for U.S. Physical Therapy is http://www.usph.com/.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]